Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR‐T

Abstract

Abstract Patients with relapsed follicular lymphoma who do not respond to CAR‐T have a poor outcome. We present a case of refractory follicular lymphoma who relapsed after two CAR‐T infusions and achieved a complete remission after treatment with obinutuzumab and lenalidomide. This represents a promising treatment option in the post‐CAR‐T setting.

Keywords

• CAR‐T
• follicular lymphoma
• immunotherapy
• lenalidomide
• obinutuzumab